- Companies
- Kinnevik
Kinnevik Valuation Multiples
Kinnevik is valued at $1.8B as of October 2026. In the last 12 months, Kinnevik EBITDA was ($93M).
Kinnevik Overview
About Kinnevik
Kinnevik AB is an operationally oriented investment group with an entrepreneurial focus on building digital brands. It concentrates its growth-style investment efforts on four sectors: TMT, e-commerce and marketplaces, Healthcare and financial services. Nearly all of its capital is committed to the communication e-commerce and marketplace sectors. The group, through its various subsidiaries, is geographically diversified and operationally present in over 80 countries. Kinnevik's bias is toward investing in emerging markets because of the opportunity afforded by these markets' reliance on legacy products and services. A key component of itsĀ is to create consumer choice of solutions in markets where supply may have been previously constrained.
Founded
1936
HQ
Employees
47
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialKinnevik Financials
Kinnevik reported last 12-month revenue of - and negative EBITDA of ($93M).
In the same LTM period, Kinnevik generated ($93M) in EBITDA losses and had net loss of ($19M).
Revenue (LTM)
Kinnevik P&L
In the most recent fiscal year, Kinnevik reported revenue of ($387M) and EBITDA of ($512M).
Kinnevik is unprofitable as of last fiscal year, with EBITDA margin of 132% and net margin of 87%.
Financial data powered by Morningstar, Inc.
Kinnevik Stock Performance
Kinnevik has current market cap of $1.8B, and enterprise value of $2B.
Market Cap Evolution
Kinnevik's stock price is $7.24.
Kinnevik share price increased by 6.1% in the last 30 days, and decreased by 23.9% in the last year.
Kinnevik has an EPS (earnings per share) of $-1.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1.8B | -0.3% | 6.1% | 30.9% | -23.9% | $-1.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKinnevik Valuation Multiples
Kinnevik trades at (5.2x) EV/Revenue multiple, and (21.4x) EV/EBITDA.
EV / Revenue (LTM)
Kinnevik Financial Valuation Multiples
As of October 17, 2026, Kinnevik has market cap of $1.8B and EV of $2B.
Kinnevik has a P/E ratio of (96.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kinnevik Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kinnevik Margins & Growth Rates
Kinnevik decreased revenue by 100% and EBITDA by 103% in the last fiscal year.
In the most recent fiscal year, Kinnevik reported EBITDA margin of 132% and net margin of 87%.
Kinnevik Margins
Kinnevik Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kinnevik Operational KPIs
Kinnevik's revenue per employee in the last FY averaged $-8.2M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Kinnevik Competitors
Kinnevik competitors include China-Singapore Suzhou, Georgia Capital, GIMV, Molten Ventures, Bure Equity, Antin Infrastructure Partners, HgCapital, Next Generation Technology Group, Fairfax India Holdings and China Everbright.
Most Kinnevik public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $481M | $332M | 7.0x | 7.1x | 10.1x | 11.8x | |||
| $733M | - | 2.3x | - | - | - | |||
| $352M | - | 6.3x | - | - | - | |||
| $200M | $178M | 8.1x | 5.0x | 9.1x | 5.4x | |||
| $27M | ($469M) | 79.5x | - | (4.6x) | - | |||
| $328M | $185M | 3.5x | 3.5x | 6.3x | 6.7x | |||
| $148M | - | 15.5x | - | - | - | |||
| $95M | $29M | 14.8x | 14.3x | 48.0x | 74.0x | |||
This data is available for Pro users. Sign up to see all Kinnevik competitors and their valuation data. Start Free Trial | ||||||||
Investments by Kinnevik
Kinnevik has invested in 73 companies to date.
Latest investment by Kinnevik was on September 23rd 2026. Kinnevik invested in Enveda Biosciences in their $311M Series E round (EV/Revenue multiple available to Pro users).
Latest Investments by Kinnevik
| Description | Enveda Biosciences is a Mountain View-based biotechnology firm using AI to map chemical structures from natural sources for drug discovery. The company has built a database of over 1 million molecules from plants, microbes, and marine organisms, analyzed via mass spectrometry and machine learning. Enveda targets inflammation, oncology, and metabolic diseases, partnering with pharmaceutical companies like Bristol Myers Squibb for lead optimization. | Tandem Health is a developer of AI-powered medical scribe software for clinicians. Automates clinical notes, referrals, and sick notes from consultations via video, phone, or in-person. Supports UK general practitioners with integration to EMIS and SystmOne EHR systems, reducing documentation time by 70 percent. | Anterior is a New York-based AI platform automating prior authorizations for health insurance coverage of medical procedures. Its clinical co-pilot, Florence, assists providers in compiling documentation to reduce denial rates and speed patient access to treatments. Launched in 2021, Anterior focuses on orthopedic, radiology, and cardiology procedures while expanding into broader administrative workflows. | Oviva is an Altendorf-headquartered digital health company delivering app-based programs for type 2 diabetes and obesity management across Europe. Launched in 2013, it partners with the UK's National Health Service to treat over 50,000 patients via personalized coaching from registered dietitians using its platform combining smartphone apps, web portals, and connected devices like scales and glucose monitors. Oviva operates clinics in Zurich, London, and Berlin, demonstrating clinical outcomes such as average 7 kg weight loss and HbA1c reductions while cutting healthcare costs through remote delivery. | |
| HQ Country | |||||
| HQ City | Boulder, CO | Stockholm | New York City, NY | Zurich | |
| Deal Date | 23 Sep 2026 | 14 Sep 2026 | 12 Feb 2026 | 22 Jan 2026 | |
| Round | Series E | Series B | Undisclosed stage | Secondary | |
| Raised | $311M | $100M | $40M | undisclosed | |
| Investors | Digitalis Ventures; Alderline Group; ICONIQ Capital; Durable Capital Partners; FPV Ventures; Premji Invest; T. Rowe Price; True Ventures; Catalio Capital Management; Lightspeed Venture Partners; Kinnevik; Dimension Capital | Amino Collective; EQT; Visionaries Club; Kinnevik; Northzone | New Enterprise Associates; FPV Ventures; Sequoia Capital; Kinnevik | EGS Beteiligungen; Norrsken VC; Planet First Partners; Kinnevik; Sofina; Lunate; A.P. Moller Holding | |
| Valuation | $2B | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Kinnevik investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kinnevik
| When was Kinnevik founded? | Kinnevik was founded in 1936. |
| Where is Kinnevik headquartered? | Kinnevik is headquartered in Sweden. |
| How many employees does Kinnevik have? | As of today, Kinnevik has over 47 employees. |
| Who is the CEO of Kinnevik? | Kinnevik's CEO is Georgi Ganev. |
| Is Kinnevik publicly listed? | Yes, Kinnevik is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Kinnevik? | Kinnevik trades under KINV A ticker. |
| When did Kinnevik go public? | Kinnevik went public in 1996. |
| Who are competitors of Kinnevik? | Kinnevik main competitors include China-Singapore Suzhou, Georgia Capital, GIMV, Molten Ventures, Bure Equity, Antin Infrastructure Partners, HgCapital, Next Generation Technology Group, Fairfax India Holdings, China Everbright. |
| What is the current market cap of Kinnevik? | Kinnevik's current market cap is $1.8B. |
| What is the current revenue growth of Kinnevik? | Kinnevik revenue growth (vs. last FY) is (100%). |
| What is the current EV/Revenue multiple of Kinnevik? | Current revenue multiple of Kinnevik is (5.2x). |
| Is Kinnevik profitable? | No, Kinnevik is not profitable. |
| What is the current EBITDA of Kinnevik? | Kinnevik has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of Kinnevik? | Current EBITDA multiple of Kinnevik is (21.4x). |
| What is the current FCF of Kinnevik? | Kinnevik's last 12 months FCF is ($60M). |
| What is the current EV/FCF multiple of Kinnevik? | Current FCF multiple of Kinnevik is (33.2x). |
| How many companies Kinnevik has acquired to date? | Kinnevik hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kinnevik has invested to date? | As of October 2026, Kinnevik has invested in 73 companies. |
| What was the last Kinnevik investment? | On 23rd September 2026 Kinnevik invested in Enveda Biosciences, participating in a $311M Series E round at $2B valuation, alongside Digitalis Ventures, Alderline Group, ICONIQ Capital, Durable Capital Partners, FPV Ventures, Premji Invest, T. Rowe Price, True Ventures, Catalio Capital Management, Lightspeed Venture Partners, and 1 other investor. |
| In what companies Kinnevik invested in? | Kinnevik invested in Babylon Holdings, Job&Talent, Rocket Internet, Global Fashion Group, Enveda Biosciences, Mews, VillageMD, Lazada Group, Oda, Lunar, Oviva, Perk, Pleo, Solugen, Transcarent, Cityblock Health, Spring Health, Aira, Vivino, Strand Therapeutics, and 53 other companies. |
See public comps similar to Kinnevik
Lists including Kinnevik
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




